Clinical Trials in Illinois

Showing 12681-12700 of 19,692 trials

Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System

NCT02672150

This is a multi site experiment to evaluate the impact of various strategies for increasing the use of evidence based screening, assessment and linkage to substance use treatment. All sites collect baseline data and receive a core intervention. Half are then randomly assigned to get an additional year of coaching to facilitate implementation.

Substance Use Disorders

Chestnut Health Systems839 participantsStarted Jul 2013

Atlanta, Georgia, United States • Bloomington, Illinois, United States • Lexington, Kentucky, United States +5 more locations

COMPLETEDPhase 2114 miles

Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer

NCT00723255

This phase II trial is studying the side effects of giving bevacizumab together with temsirolimus and to see how well it works in treating patients with recurrent or persistent endometrial cancer. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for their growth. Giving bevacizumab together with temsirolimus may kill more tumor cells.

Recurrent Endometrial Carcinoma

National Cancer Institute (NCI)53 participantsStarted Sep 2008

Hartford, Connecticut, United States • New Britain, Connecticut, United States • Washington D.C., District of Columbia, United States +38 more locations

Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System

Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer

Find Trials by Condition in Illinois

A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma

An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA

Study of Mepolizumab Safety Syringe in Asthmatics

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.

Comparative Effectiveness of Pregnancy Failure Management Regimens